Maternal MorbidityPATHNCT06941974
Partnering With Antenatal Navigators to Transform Health in Pregnancy
A study testing Patient Navigation Program in people with Maternal Morbidity and Antenatal Health, run by Northwestern University at 1 site in United States.
Trial summary
The Partnering with Antenatal Navigators to Transform Health in Pregnancy (PATH) study aims to evaluate whether an antenatal patient navigation program improves maternal health, neonatal health, pregnant women's experiences, and health care utilization outcomes among low-income pregnant women and their neonates. Read more about this study
- Who is it for?
- Ages 16 to 50 years, women only
- Conditions the study is for
- Maternal Morbidity, Antenatal Health, Neonatal Morbidity
- What is being tested?
- Patient Navigation Program
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 600 participants
- Where
- 1 siteUnited States
- Study dates
- 6 Oct 2025to 1 Jun 2030
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 to 50 years
- Women only
- No healthy volunteers
- Child, Adult
Who may be able to join
- Singleton gestation <20 weeks of gestation
- Nulliparous: no prior pregnancies ≥20 weeks excluding terminations
- Low income (public insurance or residence in a neighborhood in which >10% of household incomes are <125% of federal poverty line
- Ability to speak and read English or Spanish
- Established patient at one of practices associated with Northwestern Medical Group
- Age 16 years or older
Who cannot join
- Intent to transfer care to an outside institution
- Prior enrollment in PATH
- Concurrent enrollment in a study with competing aims/intervention
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Brittney R Williams, MPH contact
United States1 site, 1 recruiting
- Recruiting
Northwestern Memorial Hospital
Chicago, Illinois, 60611
Brittney R Williams, MPH, 312-503-3476, brittney.williams@northwestern.edu
About this study
The Partnering with Antenatal Navigators to Transform Health in Pregnancy (PATH) study aims to evaluate whether an antenatal patient navigation program improves maternal health, neonatal health, pregnant women's experiences, and health care utilization outcomes among low-income pregnant women and their neonates. Patient navigation is an individualized, barrier-focused, longitudinal, patient-centered intervention that offers support for a defined set of health services. In this randomized controlled trial, pregnant women who are randomized to receive antenatal patient navigation will be compared to pregnant women who are randomized to receive usual care. Navigators will support pregnant women from before 20 weeks of gestation through 2 weeks postpartum. The PATH intervention will be grounded in understanding and addressing factors that influence health and access to care in order to promote self-efficacy, enhance access, and sustain long-term engagement.
The main objectives of the study are to:
- Evaluate whether PATH, compared to usual care, improves maternal health outcomes. We hypothesize the PATH model of antenatal patient navigation for low-income women will reduce the incidence of a composite of adverse maternal outcomes, all of which are known to be increased among women with barriers to care.
- Evaluate whether PATH, compared to usual care, improves perinatal health outcomes. We hypothesize PATH will reduce the incidence of a composite of adverse perinatal outcomes. We will also investigate neonatal/pediatric health care utilization.
- Evaluate patient, clinician, navigator, and healthcare system experiences with PATH in preparation for widespread implementation and dissemination of the PATH obstetric navigation model. This aim will be accomplished through investigating patient-reported outcomes, completing qualitative and process mapping interviews with navigated participants, and completing qualitative and process mapping interviews with clinicians, navigators, and health administrators.
Read the detailed description
In the US, high rates of maternal morbidity are urgent public health concerns. Limited access to health care combined with other non-medical challenges generate greater risk of adverse maternal and neonatal outcomes for women with low income. High-quality antenatal care supports optimal health, yet typically fails to meet the needs of some populations, including those with lower incomes. Improving the health of pregnant women in a patient-centered manner requires innovative models of care delivery across the spectrum of maternal care. One strategy is patient navigation, a longitudinal, barrier- focused, patient-centered intervention that offers support for health services. Our prior work has included the study of patient navigation for low-income postpartum women, finding that assignment to a navigator improves the receipt of postpartum care and the successful transition to primary care. Although antenatal care is an ideal setting for patient navigation, the benefits of antenatal patient navigation for overall maternal and perinatal health have not been rigorously evaluated in randomized trials. There has been no study of antenatal patient navigation as a comprehensive, wraparound service to improve a wide range of pregnancy outcomes.
This randomized controlled trial aims to test the efficacy of an innovative antenatal care patient navigation model that extends and expands care for low-income pregnant women via the Partnering with Antenatal Navigators to Transform Health in Pregnancy (PATH) Trial. We will randomize nulliparous pregnant women with low income to receive antenatal patient navigation via the PATH program versus usual antenatal care. Participants randomized to receive PATH navigation will receive intensive, individualized patient navigation services throughout pregnancy. As a multilevel, multidomain, intervention, PATH navigation is grounded in understanding and addressing approaches to promote self-efficacy, enhance access, support communication, and sustain healthcare engagement. The PATH navigation program is a comprehensive antenatal patient navigator program which is guided by principles of barrier ascertainment and reduction, promotion of self-efficacy and health literacy skills, facilitation of communication, and enhancing antenatal care access. PATH navigators will incorporate best practices regarding non-medical needs assessment, motivational interviewing, health education, and capacity-building health behavior support.
The study will enroll and randomize 550 to 600 pregnant women, ages 16 and over, who have not had a previous live birth and who have publicly funded prenatal care or have low income. Participants assigned to navigation will be provided intensive, individualized, one-on-one navigation services from enrollment (at less than 20 weeks of gestation) through 2 weeks postpartum. All participants will undergo surveys, interviews, and medical record reviews at 5 study visits from enrollment (<20 weeks of gestation) through 9 months postpartum. Visits will occur at the following intervals: before 20 weeks (V1), 28-32 weeks of gestation (V2), at the time of hospitalization for delivery (V3), 6-12 weeks postpartum (V4), and 9 months postpartum (V5).
Aim 1 will evaluate whether PATH, compared to usual care, improves a composite of maternal adverse outcomes (including hypertensive disorders, preterm birth, postpartum hemorrhage, severe maternal morbidity, maternal mortality). Sub-Aim 1 aims to evaluate whether PATH, compared to usual care, improves effective maternal healthcare utilization (antenatal hospital use, Adequacy of Prenatal Care Utilization index, postpartum care/admission). Aim 2 will evaluate whether PATH, compared to usual care, improves a composite of perinatal adverse outcomes (including neonatal intensive care unit admission, low birthweight, small- and large-for-gestational age, perinatal death). Sub-Aim 2 aims to evaluate whether PATH, compared to usual care, improves effective neonatal/pediatric healthcare utilization (neonatal length-of-stay, neonatal hospital utilization, and pediatric care attendance). Exploratory Aims 1 and 2 will evaluate whether PATH's efficacy varies by different demographic factors (e.g. age), or chronic disease status.
Aim 3 will evaluate patient, clinician, navigator, and health system experiences with PATH in preparation for widespread implementation and dissemination of the PATH obstetric navigation model. This aim is guided by implementation science principles and will be accomplished via serial collection of patient-reported outcomes, individual interviews, and process mapping exercises. Specifically, Aim 3a will compare patient-reported outcomes, including perceived health status, quality of life, patient activation, stress level, and self-efficacy, for women who receive PATH navigation versus usual care. Aim 3b will use qualitative and process mapping methods among approximately 50 participants assigned to PATH to understand participants' engagement, feedback, pregnancy experience, antenatal care processes, and satisfaction with the level of social and medical care received with patient navigation. Aim 3c will similarly use qualitative and process mapping methods with approximately 20 clinicians, navigators, and health system administrators to understand the extent to which PATH facilitated clinical, administrative, and health system needs, as well as lessons for future program implementation, including the relative benefits of discrete elements of the PATH intervention.
The PATH Trial will fill a significant evidence gap by demonstrating whether antenatal patient navigation among low-income pregnant women, who are disproportionately at risk for adverse outcomes, is an effective strategy to improve perinatal health. The expected outcome of this project is to generate the empiric evidence needed to understand the effect of antenatal patient navigation and to plan for an optimized package of successful implementation strategies to prepare for broad dissemination.
- Conditions
- Maternal Morbidity, Antenatal Health, Neonatal Morbidity, Retention in Care, Prenatal Care
- Being tested
- Patient Navigation Program
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Patient Navigation ProgramBehavioural
PATH navigation is an antenatal patient navigator program designed to reduce barriers to care, enhance access, improve self-efficacy and knowledge, and improve multiple perinatal health outcomes. PATH navigation is a flexible, multi-pronged, patient-centered program with the capacity to evolve with patient needs and preferences. Early in pregnancy, navigators will establish themselves as a non-medical resource and will introduce PATH as a program designed to help inform, support, and connect patients during pregnancy. Navigators will review screen and address supportive and adverse non-medical needs, facilitate communication, perform logistical support, provide advocacy and bridge communication with clinical teams, and perform health education. Navigation services will be tailored to individual medical, psychosocial, or logistical complexity.
| Study group | Role | What they receive |
|---|---|---|
| Navigation Group | Experimental | Pregnant participants who are randomized to receive PATH patient navigation will be assigned to a patient navigator. The patient navigator will meet with the patient in early pregnancy for introductions, education, and assessing factors that influence health and access to care. The patient navigator will offer support and resources (e.g., appointment coordination and scheduling, communication with clinical team, transportation, community referrals, support for mental health, support for other non-medical needs, etc.). The navigator will provide support and continue linkage to resources through 2 weeks postpartum. Receives: Behavioral: Patient Navigation Program |
| Non-navigation Group | No intervention | No navigation will be provided; pregnant participants will receive usual care. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Maternal adverse outcome composite (Aim 1 primary outcome)
Frequency of maternal composite, which includes hypertensive disorders of pregnancy, preterm birth, postpartum hemorrhage, severe maternal morbidity, or maternal mortality. Components of the primary outcome will also be examined as a score and individually as secondary outcomes (see below).
Measured: Enrollment through delivery hospitalization, an average of 28 weeks
Neonatal adverse outcome composite (Aim 2 primary outcome)
Frequency of the neonatal composite, which includes neonatal intensive care unit (NICU) admission, low birthweight, small-for-gestational-age (SGA), large-for-gestational-age (LGA) status, and/or perinatal death. Components of the composite outcome will also be examined as a score and individually as secondary outcomes (see below).
Measured: At birth/delivery
Secondary outcomes (27)
Hypertensive disorder of pregnancy (component of primary outcome)
Frequency of de novo hypertensive disorder of pregnancy, including gestational hypertension, preeclampsia with or without severe features, superimposed preeclampsia on chronic hypertension, eclampsia, or HELLP syndrome
Measured: Enrollment through delivery hospitalization, an average of 28 weeks
Preterm birth (component of primary outcome)
Frequency of birth less than 37 weeks of gestation
Measured: Enrollment through delivery hospitalization, an average of 28 weeks
Postpartum hemorrhage (component of primary outcome)
Frequency of estimated/quantitative blood loss >1000mL (during delivery hospitalization) or blood transfusion
Measured: At birth/delivery
Severe maternal morbidity (component of primary outcome)
Frequency of CDC-defined indicators for severe maternal
Measured: Enrollment through delivery hospitalization, an average of 28 weeks
Maternal mortality (component of primary outcome)
Frequency of maternal death (any reason) during pregnancy or the delivery hospitalization
Measured: Enrollment through delivery hospitalization, an average of 28 weeks
Neonatal intensive care unit admission (component of Aim 2 neonatal composite outcome)
Frequency of admission to the neonatal intensive care unit
Measured: At birth/delivery
Low birthweight (component of Aim 2 neonatal composite outcome)
Frequency of birth weight <2500g
Measured: Immediately post-birth
Small-for-gestational-age (SGA) status (component of Aim 2 neonatal composite outcome)
Frequency of birth weight <10%ile for gestational age and sex
Measured: Immediately post-birth
Large-for-gestational-age (LGA) status (component of Aim 2 neonatal composite outcome)
Frequency of birth weight >90%ile for gestational age and sex
Measured: Immediately post-birth
Perinatal death (component of Aim 2 neonatal composite outcome)
Frequency of intrauterine fetal demise (>20 weeks of gestation) or neonatal death (i.e., antenatal, intrapartum, or neonatal death)
Measured: 20 weeks of gestational through birth hospitalization
Maternal health care utilization: Antenatal hospital utilization
Frequency of unanticipated obstetric triage or emergency department visit, or antepartum admission
Measured: Enrollment through delivery
Maternal health care utilization: Antenatal care adequacy
Adequacy of Prenatal Care Utilization Index score
Measured: Enrollment through delivery
Maternal health care utilization: Postpartum care
Frequency of attendance at a routine postpartum care visit within 12 weeks after delivery
Measured: Between delivery and 12 weeks after delivery
Maternal health care utilization: Postpartum admission or emergency department use
Frequency of hospital readmission or emergency department use within 9 months of delivery
Measured: Between delivery and 9 months postpartum
Neonatal health care utilization: Neonatal length of stay
Neonatal length of birth hospitalization (days)
Measured: During birth hospitalization
Neonatal health care utilization: Neonatal hospital utilization
Frequency of neonatal emergency department visit or hospital admission
Measured: From birth hospital discharge through 9 months
Neonatal health care utilization: Pediatric care attendance
Frequency of attendance at indicated neonatal/pediatric outpatient care in the recommended time frame in the first 9 months of life
Measured: From birth hospital discharge through 9 months
Patient-reported outcome: Global health status
PROMIS Global Health score
Measured: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
Patient-reported outcome: Health-related quality of life
Short Form Health Survey score
Measured: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
Patient-reported outcome: Depressive symptoms
Patient Health Questionnaire-9 score
Measured: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
Patient-reported outcome: Anxiety symptoms
General Anxiety Disorder-7 score
Measured: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
Patient-reported outcome: Health-related self-efficacy
PROMIS Self-Efficacy-General score
Measured: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
Patient-reported outcome: Patient activation
Consumer Health Activation Index score
Measured: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
Patient-reported outcome: Difficulties in pregnancy
nuMoM2b Difficulties in Pregnancy Scale score
Measured: During pregnancy, delivery hospitalization, and 6-12 weeks postpartum
Patient-reported outcome: Pregnancy experiences
nuMoM2b Pregnancy Experience Scale-Brief score
Measured: 3rd trimester, delivery hospitalization
Patient-reported outcome: Stress
Perceived Stress Scale score
Measured: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
Patient-reported outcome: Satisfaction with care (antenatal and postpartum)
Prenatal Care Satisfaction Scale score and modified scale for postpartum care satisfaction
Measured: During pregnancy, delivery hospitalization, and 6-12 weeks postpartum
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Apr 2025
- Study start6 Oct 2025
- Primary completion1 Dec 2029 (estimated)
- Study completion1 Jun 2030 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Maternal MorbidityStudies of the same condition, open and under way.
- More trials run by Northwestern UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- There will be two cohorts: One cohort will be provided intensive, individualized, one-on-one navigation services from early pregnancy (before 20 weeks of gestation) through 2 weeks postpartum. The second cohort will receive usual care. Both cohorts will be followed through 9 months postpartum.
- Masking
- None (open label)
- Enrolment
- 600 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Northwestern University
- Sponsor type
- University, hospital or other
- Collaborators
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Minority Health and Health Disparities (NIMHD)
- Responsible party
- Principal investigator, Lynn M Yee, Northwestern University
- Investigators
- Lynn M Yee, MD, MPH, Principal investigator, Northwestern University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06941974
- Sponsor's protocol ID
- STU00218597
- Other IDs
- R01MD020130
- Acronym
- PATH
- Status last verified
- Apr 2026
- First submitted
- 11 Apr 2025
- Last updated
- 6 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Partnering With Antenatal Navigators to Transform Health in Pregnancy
- ClinicalTrials.gov ID
- NCT06941974
- Acronym / sponsor ID
- PATH / STU00218597
- Conditions
- Maternal Morbidity, Antenatal Health, Neonatal Morbidity, Retention in Care, Prenatal Care
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 600 participants (estimated)
- Lead sponsor
- Northwestern UniversityUniversity, hospital or other
- Collaborators
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Minority Health and Health Disparities (NIMHD)
- Study start
- 6 Oct 2025 (actual)
- Primary completion
- 1 Dec 2029 (estimated)
- Study completion
- 1 Jun 2030 (estimated)
- First posted
- 24 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The Partnering with Antenatal Navigators to Transform Health in Pregnancy (PATH) study aims to evaluate whether an antenatal patient navigation program improves maternal health, neonatal health, pregnant women's experiences, and health care utilization outcomes among low-income pregnant women and their neonates. Patient navigation is an individualized, barrier-focused, longitudinal, patient-centered intervention that offers support for a defined set of health services. In this randomized controlled trial, pregnant women who are randomized to receive antenatal patient navigation will be compared to pregnant women who are randomized to receive usual care. Navigators will support pregnant women from before 20 weeks of gestation through 2 weeks postpartum. The PATH intervention will be grounded in understanding and addressing factors that influence health and access to care in order to promote self-efficacy, enhance access, and sustain long-term engagement.
The main objectives of the study are to:
- Evaluate whether PATH, compared to usual care, improves maternal health outcomes. We hypothesize the PATH model of antenatal patient navigation for low-income women will reduce the incidence of a composite of adverse maternal outcomes, all of which are known to be increased among women with barriers to care.
- Evaluate whether PATH, compared to usual care, improves perinatal health outcomes. We hypothesize PATH will reduce the incidence of a composite of adverse perinatal outcomes. We will also investigate neonatal/pediatric health care utilization.
- Evaluate patient, clinician, navigator, and healthcare system experiences with PATH in preparation for widespread implementation and dissemination of the PATH obstetric navigation model. This aim will be accomplished through investigating patient-reported outcomes, completing qualitative and process mapping interviews with navigated participants, and completing qualitative and process mapping interviews with clinicians, navigators, and health administrators.
Detailed description
In the US, high rates of maternal morbidity are urgent public health concerns. Limited access to health care combined with other non-medical challenges generate greater risk of adverse maternal and neonatal outcomes for women with low income. High-quality antenatal care supports optimal health, yet typically fails to meet the needs of some populations, including those with lower incomes. Improving the health of pregnant women in a patient-centered manner requires innovative models of care delivery across the spectrum of maternal care. One strategy is patient navigation, a longitudinal, barrier- focused, patient-centered intervention that offers support for health services. Our prior work has included the study of patient navigation for low-income postpartum women, finding that assignment to a navigator improves the receipt of postpartum care and the successful transition to primary care. Although antenatal care is an ideal setting for patient navigation, the benefits of antenatal patient navigation for overall maternal and perinatal health have not been rigorously evaluated in randomized trials. There has been no study of antenatal patient navigation as a comprehensive, wraparound service to improve a wide range of pregnancy outcomes.
This randomized controlled trial aims to test the efficacy of an innovative antenatal care patient navigation model that extends and expands care for low-income pregnant women via the Partnering with Antenatal Navigators to Transform Health in Pregnancy (PATH) Trial. We will randomize nulliparous pregnant women with low income to receive antenatal patient navigation via the PATH program versus usual antenatal care. Participants randomized to receive PATH navigation will receive intensive, individualized patient navigation services throughout pregnancy. As a multilevel, multidomain, intervention, PATH navigation is grounded in understanding and addressing approaches to promote self-efficacy, enhance access, support communication, and sustain healthcare engagement. The PATH navigation program is a comprehensive antenatal patient navigator program which is guided by principles of barrier ascertainment and reduction, promotion of self-efficacy and health literacy skills, facilitation of communication, and enhancing antenatal care access. PATH navigators will incorporate best practices regarding non-medical needs assessment, motivational interviewing, health education, and capacity-building health behavior support.
The study will enroll and randomize 550 to 600 pregnant women, ages 16 and over, who have not had a previous live birth and who have publicly funded prenatal care or have low income. Participants assigned to navigation will be provided intensive, individualized, one-on-one navigation services from enrollment (at less than 20 weeks of gestation) through 2 weeks postpartum. All participants will undergo surveys, interviews, and medical record reviews at 5 study visits from enrollment (<20 weeks of gestation) through 9 months postpartum. Visits will occur at the following intervals: before 20 weeks (V1), 28-32 weeks of gestation (V2), at the time of hospitalization for delivery (V3), 6-12 weeks postpartum (V4), and 9 months postpartum (V5).
Aim 1 will evaluate whether PATH, compared to usual care, improves a composite of maternal adverse outcomes (including hypertensive disorders, preterm birth, postpartum hemorrhage, severe maternal morbidity, maternal mortality). Sub-Aim 1 aims to evaluate whether PATH, compared to usual care, improves effective maternal healthcare utilization (antenatal hospital use, Adequacy of Prenatal Care Utilization index, postpartum care/admission). Aim 2 will evaluate whether PATH, compared to usual care, improves a composite of perinatal adverse outcomes (including neonatal intensive care unit admission, low birthweight, small- and large-for-gestational age, perinatal death). Sub-Aim 2 aims to evaluate whether PATH, compared to usual care, improves effective neonatal/pediatric healthcare utilization (neonatal length-of-stay, neonatal hospital utilization, and pediatric care attendance). Exploratory Aims 1 and 2 will evaluate whether PATH's efficacy varies by different demographic factors (e.g. age), or chronic disease status.
Aim 3 will evaluate patient, clinician, navigator, and health system experiences with PATH in preparation for widespread implementation and dissemination of the PATH obstetric navigation model. This aim is guided by implementation science principles and will be accomplished via serial collection of patient-reported outcomes, individual interviews, and process mapping exercises. Specifically, Aim 3a will compare patient-reported outcomes, including perceived health status, quality of life, patient activation, stress level, and self-efficacy, for women who receive PATH navigation versus usual care. Aim 3b will use qualitative and process mapping methods among approximately 50 participants assigned to PATH to understand participants' engagement, feedback, pregnancy experience, antenatal care processes, and satisfaction with the level of social and medical care received with patient navigation. Aim 3c will similarly use qualitative and process mapping methods with approximately 20 clinicians, navigators, and health system administrators to understand the extent to which PATH facilitated clinical, administrative, and health system needs, as well as lessons for future program implementation, including the relative benefits of discrete elements of the PATH intervention.
The PATH Trial will fill a significant evidence gap by demonstrating whether antenatal patient navigation among low-income pregnant women, who are disproportionately at risk for adverse outcomes, is an effective strategy to improve perinatal health. The expected outcome of this project is to generate the empiric evidence needed to understand the effect of antenatal patient navigation and to plan for an optimized package of successful implementation strategies to prepare for broad dissemination.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- There will be two cohorts: One cohort will be provided intensive, individualized, one-on-one navigation services from early pregnancy (before 20 weeks of gestation) through 2 weeks postpartum. The second cohort will receive usual care. Both cohorts will be followed through 9 months postpartum.
| Arm | Type | Receives |
|---|---|---|
| Navigation Group | Experimental | Behavioral: Patient Navigation ProgramPregnant participants who are randomized to receive PATH patient navigation will be assigned to a patient navigator. The patient navigator will meet with the patient in early pregnancy for introductions, education, and assessing factors that influence health and access to care. The patient navigator will offer support and resources (e.g., appointment coordination and scheduling, communication with clinical team, transportation, community referrals, support for mental health, support for other non-medical needs, etc.). The navigator will provide support and continue linkage to resources through 2 weeks postpartum. |
| Non-navigation Group | No intervention | –No navigation will be provided; pregnant participants will receive usual care. |
Who may qualify
- Ages
- 16 to 50 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (6 listed)
- Singleton gestation <20 weeks of gestation
- Nulliparous: no prior pregnancies ≥20 weeks excluding terminations
- Low income (public insurance or residence in a neighborhood in which >10% of household incomes are <125% of federal poverty line
- Ability to speak and read English or Spanish
- Established patient at one of practices associated with Northwestern Medical Group
Key exclusion criteria (3 listed)
- Intent to transfer care to an outside institution
- Prior enrollment in PATH
- Concurrent enrollment in a study with competing aims/intervention
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Patient Navigation ProgramPATH navigation is an antenatal patient navigator program designed to reduce barriers to care, enhance access, improve self-efficacy and knowledge, and improve multiple perinatal health outcomes. PATH navigation is a flexible, multi-pronged, patient-centered program with the capacity to evolve with patient needs and preferences. Early in pregnancy, navigators will establish themselves as a non-medical resource and will introduce PATH as a program designed to help inform, support, and connect patients during pregnancy. Navigators will review screen and address supportive and adverse non-medical needs, facilitate communication, perform logistical support, provide advocacy and bridge communication with clinical teams, and perform health education. Navigation services will be tailored to individual medical, psychosocial, or logistical complexity. | Behavioural | Navigation Group |
Primary outcome
Maternal adverse outcome composite (Aim 1 primary outcome)
Time frame: Enrollment through delivery hospitalization, an average of 28 weeks
Frequency of maternal composite, which includes hypertensive disorders of pregnancy, preterm birth, postpartum hemorrhage, severe maternal morbidity, or maternal mortality. Components of the primary outcome will also be examined as a score and individually as secondary outcomes (see below).
Neonatal adverse outcome composite (Aim 2 primary outcome)
Time frame: At birth/delivery
Frequency of the neonatal composite, which includes neonatal intensive care unit (NICU) admission, low birthweight, small-for-gestational-age (SGA), large-for-gestational-age (LGA) status, and/or perinatal death. Components of the composite outcome will also be examined as a score and individually as secondary outcomes (see below).
27 secondary outcomes
Hypertensive disorder of pregnancy (component of primary outcome)
Time frame: Enrollment through delivery hospitalization, an average of 28 weeks
Preterm birth (component of primary outcome)
Time frame: Enrollment through delivery hospitalization, an average of 28 weeks
Postpartum hemorrhage (component of primary outcome)
Time frame: At birth/delivery
Severe maternal morbidity (component of primary outcome)
Time frame: Enrollment through delivery hospitalization, an average of 28 weeks
Maternal mortality (component of primary outcome)
Time frame: Enrollment through delivery hospitalization, an average of 28 weeks
Neonatal intensive care unit admission (component of Aim 2 neonatal composite outcome)
Time frame: At birth/delivery
Low birthweight (component of Aim 2 neonatal composite outcome)
Time frame: Immediately post-birth
Small-for-gestational-age (SGA) status (component of Aim 2 neonatal composite outcome)
Time frame: Immediately post-birth
Large-for-gestational-age (LGA) status (component of Aim 2 neonatal composite outcome)
Time frame: Immediately post-birth
Perinatal death (component of Aim 2 neonatal composite outcome)
Time frame: 20 weeks of gestational through birth hospitalization
Maternal health care utilization: Antenatal hospital utilization
Time frame: Enrollment through delivery
Maternal health care utilization: Antenatal care adequacy
Time frame: Enrollment through delivery
Maternal health care utilization: Postpartum care
Time frame: Between delivery and 12 weeks after delivery
Maternal health care utilization: Postpartum admission or emergency department use
Time frame: Between delivery and 9 months postpartum
Neonatal health care utilization: Neonatal length of stay
Time frame: During birth hospitalization
Neonatal health care utilization: Neonatal hospital utilization
Time frame: From birth hospital discharge through 9 months
Neonatal health care utilization: Pediatric care attendance
Time frame: From birth hospital discharge through 9 months
Patient-reported outcome: Global health status
Time frame: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
Patient-reported outcome: Health-related quality of life
Time frame: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
Patient-reported outcome: Depressive symptoms
Time frame: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
Patient-reported outcome: Anxiety symptoms
Time frame: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
Patient-reported outcome: Health-related self-efficacy
Time frame: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
Patient-reported outcome: Patient activation
Time frame: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
Patient-reported outcome: Difficulties in pregnancy
Time frame: During pregnancy, delivery hospitalization, and 6-12 weeks postpartum
Patient-reported outcome: Pregnancy experiences
Time frame: 3rd trimester, delivery hospitalization
Patient-reported outcome: Stress
Time frame: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
Patient-reported outcome: Satisfaction with care (antenatal and postpartum)
Time frame: During pregnancy, delivery hospitalization, and 6-12 weeks postpartum
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Apr 2026.
- Individual participant dataSharing planned: No
Related trials for Maternal Morbidity
Active, not recruiting
Implementation of a Disparities in Labor Outcomes Dashboard
Labor Induction, Cesarean Birth
Active, not recruiting
The Maternal Health Multilevel Intervention for Racial Equity (MIRACLE) Project
Maternal Morbidity and Mortality, Health Disparities
Recruiting
Scaling up Maternal Health Equity Best Practices
Maternal Mortality Disparities, Maternal Morbidity Disparities
Not yet recruiting
Community Support and Mobile Apps to Help Black Women Control High Blood Pressure After Pregnancy
Hypertensive Disorders of Pregnancy (HDP), Hypertension, Pregnancy Induced
Recruiting
Amnioinfusion for Chorioamnionitis: Targeting Neonatal Brain Injury Biomarkers
Chorioamnionitis Affecting Fetus or Newborn, Amnioinfusion
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Brittney R Williams, MPH contact
Lynn M Yee, MD, MPH principal investigator
Northwestern University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Patient Navigation Program in people with Maternal Morbidity and Antenatal Health, run by Northwestern University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 6 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Lynn M Yee, MD, MPH (312-472-0119, lynn.yee@northwestern.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Maternal adverse outcome composite (Aim 1 primary outcome) (time frame: Enrollment through delivery hospitalization, an average of 28 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2026.